Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06304142

Effect of Lidocaine Block on Gastroesophageal Reflux Disease

A Randomized Controlled Study to Explore Clinical Effect of Lidocaine Block on Gastroesophageal Reflux Disease

Sponsor: Muhammad

Conditions Gastroesophageal Reflux Disease

Interventions Injection Lidocaine hydrochloride Rehabilitation therapy

Updated 3 times since 2024 Last updated: Mar 11, 2024 Started: Mar 31, 2024 Primary completion: Jun 30, 2024 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06304142, this NA trial focuses on Gastroesophageal Reflux Disease and remains actively recruiting participants. Sponsored by Muhammad, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Muhammad

Data source: Ahmadu Bello University Teaching Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.